Zobrazeno 1 - 4
of 4
pro vyhledávání: '"острая лимфобластная лейкемия"'
Autor:
Maslova, H. S., Skrypnyk, I. M.
Publikováno v:
Буковинський медичний вісник; Том 24, № 2 (94) (2020); 63-69
Буковинский медицинский вестник; Том 24, № 2 (94) (2020); 63-69
Bukovinian Medical Herald; Том 24, № 2 (94) (2020); 63-69
Буковинский медицинский вестник; Том 24, № 2 (94) (2020); 63-69
Bukovinian Medical Herald; Том 24, № 2 (94) (2020); 63-69
Objective – to investigate the role of arginase, ornithine decarboxylase (ODC) activity in the liver injury pathogenesis in patients with acute myeloid (AML) and acute lymphoblastic (ALL) leukemia with concomitant obesity.Materials and methods. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::94123b09fbf40d7c19a19fad212db9b3
http://e-bmv.bsmu.edu.ua/article/view/2413-0737.XXIV.2.94.2020.45
http://e-bmv.bsmu.edu.ua/article/view/2413-0737.XXIV.2.94.2020.45
Autor:
Skrypnyk, I. M., Maslova, G. S.
Publikováno v:
Украинский терапевтический журнал; № 2 (2020); 14-19
Український терапевтичний журнал; № 2 (2020); 14-19
Ukrainian Therapeutical Journal; № 2 (2020); 14-19
Український терапевтичний журнал; № 2 (2020); 14-19
Ukrainian Therapeutical Journal; № 2 (2020); 14-19
Objective — to evaluate the effectiveness of S-ademetionine and ursodeoxycholic acid (UDCA) combined use in the prevention of hepatotoxic reactions during chemotherapy (CT) in patients with acute lymphoblastic leukemia (ALL) and concomitant obesity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::3de6706a93e64e4d8796ffd43c74f13a
http://utj.com.ua/article/view/206839
http://utj.com.ua/article/view/206839
Autor:
I. M. Skrypnyk, G. S. Maslova
Publikováno v:
Ukrainian Therapeutical Journal; № 1 (2019); 57-62
Украинский терапевтический журнал; № 1 (2019); 57-62
Український терапевтичний журнал; № 1 (2019); 57-62
Украинский терапевтический журнал; № 1 (2019); 57-62
Український терапевтичний журнал; № 1 (2019); 57-62
The specific chemotherapy (CT) in patients with acute lymphoblastic leukemia (ALL) is accompanied by a risk of the liver functional state violation. However, there are still many unsolved questions regarding the hepatotoxicity of cytostatic drugs, si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654d6b17c016bd76514bd06d50905a11
http://utj.com.ua/article/view/165173
http://utj.com.ua/article/view/165173
Autor:
Dorosh, O. I., Myh, A. M., Stepanyuk, A. I., Kozlova, O. I., Skoropad, L. L., Seredych, L. P., Tsymbalyuk-Voloshyn, I. P.
Publikováno v:
Сучасна педіатрія; № 4(92) (2018): Сучасна педіатрія; 69-80
Современная педиатрия; № 4(92) (2018): Современная педиатрия; 69-80
Sovremennaya pediatriya; № 4(92) (2018): Sovremennaya pediatriya; 69-80
Современная педиатрия; № 4(92) (2018): Современная педиатрия; 69-80
Sovremennaya pediatriya; № 4(92) (2018): Sovremennaya pediatriya; 69-80
The article presents two clinical cases of secondary treatment-related haemoblastosis – treatment-related myelodisplastic syndrome (t-MDS)/treatment-related acute myeloid leukaemia (AML) – t-MDS/t-AML, compared to the data of other world's invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::892a99b0c2834f9973e8868da35dabf6
http://sp.med-expert.com.ua/article/view/SP.2018.92.69
http://sp.med-expert.com.ua/article/view/SP.2018.92.69